Basma Adeem Medical Co. (9626) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, Basma Adeem Medical Co. reported revenue of SAR 45M, net profit of SAR 7M, and earnings per share of SAR 0.40. Total assets stood at SAR 66M with total equity of SAR 46M and total liabilities of SAR 20M.

Operating cash flow for 2025 was SAR 11M, representing a cash conversion ratio of 1.56 relative to net profit. Free cash flow was SAR 5M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 1.56 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 1.56.

Revenue growth from 2024 to 2025: +34.0%. Net profit growth over the same period: +15.9%.

Key financial ratios for 2025: Return on Equity 15.8%, Return on Assets 11.0%, Net Margin 16.1%, Debt to Equity 0.44.

In 2024, Basma Adeem Medical Co. reported revenue of SAR 34M and net profit of SAR 6M, compared to SAR 45M and SAR 7M respectively in 2025.